Total Infectome Characterization of Eye Infections
NCT06775808 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-07-17
Summary
Multiple pathogens can cause eye infection. In recent years, emerging and resurging viral infections represent an important public health problem. Many emerging viruses cause infectious diseases involving ophthalmic manifestations, including Mpox virus, Zika, Ebola, and SARS-CoV-2. Broad and unbiased pathogen surveillance is essential, so we design this unbiased metagenomic sequencing based study to investigate the total infectome of eye infections. The study is historical and prospective in design.
Conditions
- Eye Infections
- Diagnosis
Sponsors & Collaborators
-
Shanghai Fourth People's Hospital Tongji University
collaborator OTHER -
The Central Hospital of Huanggang
collaborator OTHER -
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
lead OTHER
Principal Investigators
-
Shuo Su, PhD · Fudan University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-25
- Primary Completion
- 2026-10-30
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Application of NGS Technique in Precise Diagnosis of Infectious Diseases
NCT03232242 ·Status: UNKNOWN
-
Detection of Efflux Pump Genes Mediating Ciprofloxacin Resistance in Staphylococcus Aureus Isolates in Sohag University Hospitals
NCT05828550 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of (Bio)Sensors for the Identification of Pathogens
NCT06548841 ·Status: COMPLETED
-
Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening
NCT01918813 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI
NCT06519032 ·Status: RECRUITING
-
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
NCT01359358 ·Status: UNKNOWN
-
Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
NCT04708912 ·Status: UNKNOWN
-
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
NCT05256316 ·Status: COMPLETED
-
NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis
NCT04257292 ·Status: UNKNOWN
-
Biotherapy for MRSA Enterocolitis
NCT02390622 ·Status: UNKNOWN ·Phase: NA
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System
NCT04860895 ·Status: UNKNOWN ·Phase: NA
-
Antibiotics Resistance Gene in Healthcare Workers
NCT06228248 ·Status: COMPLETED
-
TOcilizumab and Covid-19 : Risk of Severe INfection
NCT05017441 ·Status: UNKNOWN
-
Toxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies
NCT05963295 ·Status: UNKNOWN ·Phase: NA
-
Impact MRSA -PCR on Patient Management
NCT03096405 ·Status: COMPLETED
-
The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
NCT04884490 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Invasive Markers of Staphylococcus Epidermidis
NCT03374371 ·Status: COMPLETED
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
NCT04312776 ·Status: COMPLETED
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
NCT06805994 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA